Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sandercock

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Age and Ageing|March 30, 2004
Effects of introducing an integrated care pathway in an acute stroke unitJoseph Kwan, Peter Hand, Martin Dennis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 22, 2011
Should mechanical embolectomy devices be used in routine clinical practice?Michal Bar, Peter Sandercock, David Skoloudik, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 22, 2010
How many patients might receive thrombolytic therapy in the light of the ECASS-3 and IST-3 data?Jan Bembenek, Adam Kobayashi, Peter Sandercock, et al.
Stroke|January 6, 2007
Systematic review and meta-analysis of the efficacy of tirilazad in experimental strokeEmily Sena, Philippa Wheble, Peter Sandercock, et al.
Controlled Clinical Trials|February 26, 2004
Follow-up by mail in clinical trials: does questionnaire length matter?Phil Edwards, Ian Roberts, Peter Sandercock, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Third international stroke trialWilliam Whiteley, Richard Lindley, Joanna Wardlaw, et al.
Clinical Evidence|September 17, 2002
Stroke preventionCathie Sudlow, Gord Gubitz, Peter Sandercock, et al.
Journal of Psychosomatic Research|November 29, 2011
Hoover's sign for the diagnosis of functional weakness: a prospective unblinded cohort study in patients with suspected strokeLaura McWhirter, Jon Stone, Peter Sandercock, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 24, 2006
Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke TrialIngrid Kane, Richard Lindley, Steff Lewis, et al.
Trials|March 19, 2013
Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: statistical analysis planMartin Dennis, Peter Sandercock, Gordon Murray, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Age and Ageing|March 30, 2004
Effects of introducing an integrated care pathway in an acute stroke unitJoseph Kwan, Peter Hand, Martin Dennis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 22, 2011
Should mechanical embolectomy devices be used in routine clinical practice?Michal Bar, Peter Sandercock, David Skoloudik, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 22, 2010
How many patients might receive thrombolytic therapy in the light of the ECASS-3 and IST-3 data?Jan Bembenek, Adam Kobayashi, Peter Sandercock, et al.
Stroke|January 6, 2007
Systematic review and meta-analysis of the efficacy of tirilazad in experimental strokeEmily Sena, Philippa Wheble, Peter Sandercock, et al.
Controlled Clinical Trials|February 26, 2004
Follow-up by mail in clinical trials: does questionnaire length matter?Phil Edwards, Ian Roberts, Peter Sandercock, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Third international stroke trialWilliam Whiteley, Richard Lindley, Joanna Wardlaw, et al.
Clinical Evidence|September 17, 2002
Stroke preventionCathie Sudlow, Gord Gubitz, Peter Sandercock, et al.
Journal of Psychosomatic Research|November 29, 2011
Hoover's sign for the diagnosis of functional weakness: a prospective unblinded cohort study in patients with suspected strokeLaura McWhirter, Jon Stone, Peter Sandercock, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 24, 2006
Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke TrialIngrid Kane, Richard Lindley, Steff Lewis, et al.
Trials|March 19, 2013
Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: statistical analysis planMartin Dennis, Peter Sandercock, Gordon Murray, et al.
Pageof 14